Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models
Title:
Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models
Author:
Thibaut de Ménonville, Séverine Rosignoli, Carine Soares, Estelle Roquet, Manon Bertino, Béatrice Chappuis, Jean-Paul Defoin-Platel/Chaussade, Claire Piwnica, David